IL17A and neoplasm: Interleukin‐17A (IL‐17A), the production of which characterizes a subset of CD4+ helper T cells (Th17 cells), has been implicated in certain tumours, affecting tumorigenesis, proliferation and angiogenesis (Song and Yang, 2017).